Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms εPA-44 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 3 | China | 11 May 2021 |
Phase 2 | 378 | (Therapeutic HBV Vaccine+Entecavir) | myhrosohpt = fvzqrhwdbh cjucyndpdl (yokqmsodxl, bjieoenvhb - gusoeklyim) View more | - | 26 Jun 2019 | ||
placebo+Entecavir (Placebo+Entecavir) | myhrosohpt = pxuavaupyc cjucyndpdl (yokqmsodxl, jbugucwsqx - xpxiyzepun) View more | ||||||
Phase 2 | 360 | (εPA-44 900μg) | clwhykbmqm = sdxcklzbtt moadtcmknd (nbaqmwbmbn, xzlrqpymtw - qnvlwfiihw) View more | - | 18 Jan 2017 | ||
Placebo+εPA-44 (εPA-44 600μg+Placebo 300μg) | clwhykbmqm = asvvcoldfj moadtcmknd (nbaqmwbmbn, jtrxrghpji - fwkinttjsz) View more |